SCHEMBL30768437

SCHEMBL30768437

CC(C)(C)OC(=O)N1CCC(Nc2ccc(-c3ccc(OCc4ccccc4)nc3OCc3ccccc3)cc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 4/20 0.54
ALDH1A1 P00352 3/20 0.51
MAPT P10636 3/20 0.50
MAPK1 P28482 3/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
NPC1 O15118 1/20 0.50
HTT P42858 1/20 0.50
RAB9A P51151 1/20 0.50
CACNA1B Q00975 1/20 0.45
CCNT1 O60563 1/20 0.44
CCNA2 P20248 1/20 0.44
CDK2 P24941 1/20 0.44
CDK9 P50750 1/20 0.44
CCNA1 P78396 1/20 0.44
GPR119 Q8TDV5 1/20 0.44
PTPN2 P17706 1/20 0.43
PTPN1 P18031 1/20 0.43
PTPN6 P29350 1/20 0.43
NPSR1 Q6W5P4 2/20 0.43
YAP1 P46937 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30706131 0.88 PRMT5 (0.56) PRMT5GPR119YAP1BRD4
SCHEMBL30706137 0.88 PRMT5 (0.49) PRMT5CCNT1CCNA2CDK2CDK9
SCHEMBL24206930 0.87 PRMT5 (0.52) PRMT5GPR119YAP1STS
SCHEMBL25190804 0.86 PRMT5 (0.41) PRMT5ALDH1A1MAPTMAPK1L3MBTL1
SCHEMBL25190805 0.86 PRMT5 (0.41) PRMT5ALDH1A1MAPTMAPK1L3MBTL1
SCHEMBL29223506 0.85 PRMT5 (0.53) PRMT5CACNA1BGPR119YAP1
SCHEMBL23301621 0.85 GPR119 (0.54) ALDH1A1MAPTGPR119ACHE
SCHEMBL31382255 0.85 PRMT5 (0.53) PRMT5GPR119YAP1STS
SCHEMBL25168313 0.84 DDB1 (0.51) PRMT5ALDH1A1MAPTMAPK1L3MBTL1
SCHEMBL25074065 0.84 GPR119 (0.51) PRMT5CACNA1BGPR119YAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543871-A1 ESTROGEN RECEPTOR ALPHA DEGRADERS AND USE THEREOF Relay Therapeutics, Inc. (US) 2025-04-30 EP disclosed
WO-2024006781-A1 ESTROGEN RECEPTOR ALPHA DEGRADERS AND USE THEREOF RELAY THERAPEUTICS, INC. (US) 2024-01-04 WO disclosed